These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
172 related items for PubMed ID: 38426107
1. Urinary miR-185-5p is a biomarker of renal tubulointerstitial fibrosis in IgA nephropathy. Duan ZY, Bu R, Liang S, Chen XZ, Zhang C, Zhang QY, Li JJ, Chen XM, Cai GY. Front Immunol; 2024; 15():1326026. PubMed ID: 38426107 [Abstract] [Full Text] [Related]
2. Urinary exosomal miRNA-451a can be used as a potential noninvasive biomarker for diagnosis, reflecting tubulointerstitial damage and therapeutic response in IgA nephropathy. Zhang Q, Zhao Y, Luo Y, Guo S, Hou H, Han X, Zhou Y. Ren Fail; 2024 Dec; 46(1):2319326. PubMed ID: 38379319 [Abstract] [Full Text] [Related]
3. Relationship between blood neutrophil-lymphocyte ratio and renal tubular atrophy/interstitial fibrosis in IgA nephropathy patients. Chai L, Cai K, Wang K, Luo Q. J Clin Lab Anal; 2021 Jun; 35(6):e23774. PubMed ID: 33951240 [Abstract] [Full Text] [Related]
4. Urinary miR-16-5p can be used as a potential marker of endocapillary hypercellularity in IgA nephropathy. Zhang M, Duan ZY, Zhang QY, Xu XG, Zhang Y, Wang P, Duan SW, Wu J, Chen XM, Cai GY. Sci Rep; 2023 Apr 13; 13(1):6048. PubMed ID: 37055445 [Abstract] [Full Text] [Related]
5. Urinary sediment miRNAs reflect tubulointerstitial damage and therapeutic response in IgA nephropathy. Liang S, Cai GY, Duan ZY, Liu SW, Wu J, Lv Y, Hou K, Li ZX, Zhang XG, Chen XM. BMC Nephrol; 2017 Feb 15; 18(1):63. PubMed ID: 28201996 [Abstract] [Full Text] [Related]
6. Blood TGF-β1 and miRNA-21-5p levels predict renal fibrosis and outcome in IgA nephropathy. Bharti N, Agrawal V, Kamthan S, Prasad N, Agarwal V. Int Urol Nephrol; 2023 Jun 15; 55(6):1557-1564. PubMed ID: 36648741 [Abstract] [Full Text] [Related]
7. Development and validation of a diagnostic nomogram to evaluate tubular atrophy/interstitial fibrosis of IgA nephropathy. Gan Y, Cai Y, Li J, Wu J, Zhang R, Han Q, Li W, Yang Q. Int J Med Sci; 2024 Jun 15; 21(4):674-680. PubMed ID: 38464822 [Abstract] [Full Text] [Related]
8. Differential expression of urinary exosomal microRNAs in IgA nephropathy. Min QH, Chen XM, Zou YQ, Zhang J, Li J, Wang Y, Li SQ, Gao QF, Sun F, Liu J, Xu YM, Lin J, Huang LF, Huang B, Wang XZ. J Clin Lab Anal; 2018 Feb 15; 32(2):. PubMed ID: 28383146 [Abstract] [Full Text] [Related]
9. Tubular decoy receptor 2 as a predictor of prognosis in patients with immunoglobulin A nephropathy. Dai H, Hu W, Lin L, Wang L, Chen J, He Y. Clin Kidney J; 2021 May 15; 14(5):1458-1468. PubMed ID: 33959273 [Abstract] [Full Text] [Related]
10. Serum miR-192 Is Related to Tubulointerstitial Lesion and Short-Term Disease Progression in IgA Nephropathy. Fan Q, Lu R, Zhu M, Yan Y, Guo X, Qian Y, Zhang L, Dai H, Ni Z, Gu L. Nephron; 2019 May 15; 142(3):195-207. PubMed ID: 30808829 [Abstract] [Full Text] [Related]
11. Selection of urinary sediment miRNAs as specific biomarkers of IgA nephropathy. Duan ZY, Cai GY, Bu R, Lu Y, Hou K, Chen XM. Sci Rep; 2016 Mar 22; 6():23498. PubMed ID: 27000966 [Abstract] [Full Text] [Related]
12. Profiling and initial validation of urinary microRNAs as biomarkers in IgA nephropathy. Wang N, Bu R, Duan Z, Zhang X, Chen P, Li Z, Wu J, Cai G, Chen X. PeerJ; 2015 Mar 22; 3():e990. PubMed ID: 26056621 [Abstract] [Full Text] [Related]
13. A validation study of crescents in predicting ESRD in patients with IgA nephropathy. Zhang X, Shi S, Ouyang Y, Yang M, Shi M, Pan X, Lv J, Wang Z, Ren H, Shen P, Wang W, Zhang H, Xie J, Chen N. J Transl Med; 2018 May 03; 16(1):115. PubMed ID: 29724226 [Abstract] [Full Text] [Related]
14. miR-21-5p renal expression is associated with fibrosis and renal survival in patients with IgA nephropathy. Hennino MF, Buob D, Van der Hauwaert C, Gnemmi V, Jomaa Z, Pottier N, Savary G, Drumez E, Noël C, Cauffiez C, Glowacki F. Sci Rep; 2016 Jun 06; 6():27209. PubMed ID: 27264483 [Abstract] [Full Text] [Related]
15. Clinical significance of IgM and C3 deposition in children with primary immunoglobulin A nephropathy. Xiong L, Liu L, Tao Y, Guo H. J Nephrol; 2023 Nov 06; 36(8):2213-2222. PubMed ID: 37542609 [Abstract] [Full Text] [Related]
16. Discovery of Fibrinogen γ-chain as a potential urinary biomarker for renal interstitial fibrosis in IgA nephropathy. Guan J, Wang M, Zhao M, Ni W, Zhang M. BMC Nephrol; 2023 Mar 20; 24(1):60. PubMed ID: 36941570 [Abstract] [Full Text] [Related]
17. Clinical significance of urinary exosomal microRNAs in patients with IgA nephropathy. Yoon SY, Kim JS, Jung SW, Kim YG, Hwang HS, Moon JY, Lee SH, Seo JW, Seok J, Tae D, Jeong K. Sci Rep; 2023 Oct 11; 13(1):17201. PubMed ID: 37821628 [Abstract] [Full Text] [Related]
18. The correlation analysis between the Oxford classification of Chinese IgA nephropathy children and renal outcome - a retrospective cohort study. Wu H, Xia Z, Gao C, Zhang P, Yang X, Wang R, Wang M, Peng Y. BMC Nephrol; 2020 Jul 01; 21(1):247. PubMed ID: 32611399 [Abstract] [Full Text] [Related]
19. The predictive value of free thyroxine combined with tubular atrophy/interstitial fibrosis for poor prognosis in patients with IgA nephropathy. Yang B, Zhou W, Cui L, Tian L, Ni Y, Yang M, Yang Y. Front Endocrinol (Lausanne); 2024 Jul 01; 15():1372824. PubMed ID: 38808109 [Abstract] [Full Text] [Related]
20. Validation of the Oxford classification of IgA nephropathy for pediatric patients from China. Le W, Zeng CH, Liu Z, Liu D, Yang Q, Lin RX, Xia ZK, Fan ZM, Zhu G, Wu Y, Xu H, Zhai Y, Ding Y, Yang X, Liang S, Chen H, Xu F, Huang Q, Shen H, Wang J, Fogo AB, Liu ZH. BMC Nephrol; 2012 Nov 27; 13():158. PubMed ID: 23181565 [Abstract] [Full Text] [Related] Page: [Next] [New Search]